{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-036852","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2024-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.235174+00:00","generated_at":"2026-05-31T04:17:39.789120+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vivos Therapeutics sets 2024 Annual Meeting for Nov 26; Oct 4 record date; Sep 27 deadline for proposals","bullets":["2024 Annual Meeting scheduled for Tuesday, November 26, 2024.","Record date for voting set at close of business on October 4, 2024.","Stockholder proposals under Rule 14a-8 must be received by September 27, 2024.","Director nominations and non-proxy proposals also due by September 27, 2024.","Address for submissions: Corporate Secretary, Vivos Therapeutics, Inc., 7921 Southpark Plaza, Suite 210, Littleton, CO 80120."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-036852","json":"https://secwatch.observer/filing/0001493152-24-036852.json","markdown":"https://secwatch.observer/filing/0001493152-24-036852.md","text":"https://secwatch.observer/filing/0001493152-24-036852.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224036852/0001493152-24-036852-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224036852/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:17:39.789120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}